// App-Quantinova.ai

14247 2014 BOS : Risk of Intracranial Hemorrhage Among Acute Ischemic Stroke Patients Receiving Prior Antiplatelet Therapy and Treated with Intravenous Tissue Plasminogen Activator

Researchers

Presenter

  • Maria Grau-Spulveda

Principal Investigators

  • Lee H Schwamm

  • Gregg C Fonarow

  • Eric D Peterson

  • Deepak L Bhatt

  • Eric E Smith

  • Mathew J Reeves

  • Jerome Federspiel

  • Laine Thomas

  • Janet P Bettger

  • Daniel T Laskowitz

  • Adrian F Hernandez

Medical Centers

  • Massachusetts General Hospital, Boston, MA

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • University of North Carolina, Chapel Hill, NC

  • UCLA, Los Angeles, CA

  • Univ of Calgary, Alberta, AB, Canada

  • Michigan State University, Lansing, MI

  • Duke Hosp, Durham, NC

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved